A 38-year-old woman presented with "moon face," "buffalo hump," and weight gain of 9 kg in 12 months. Overnight, 1 mg dexamethasone failed to suppress the morning level of cortisol, and the 24-hour urine cortisol level was elevated to 101 μg/day (normal range 0 -50). Initial contrast-enhanced abdominal computed tomography (CT) showed a 2.8-cm left adrenal mass enhanced in arterial phase, and the patient was diagnosed with Cushing's syndrome due to left adrenal adenoma (▶ Fig. 1 a) . She refused surgical treatment but agreed to undergo endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA; STARmed, Koyang, Korea) (▶ Video 1). Prior to RFA, contrast-enhanced EUS with SonoVue (Bracco, Inc., Milan, Italy) was performed. Findings of early enhancement and delayed washout were compatible with adrenal adenoma (▶ Fig. 2 a) . A 19-guage needle electrode was positioned inside the adenoma. Using realtime EUS imaging, RFA (50 W) was performed at five different sites (▶ Fig. 2 b) . Four days later contrast-enhanced EUS revealed viable tissue remaining at the marginal edge of the previously ablated portion of the adenoma (▶ Fig. 3 a) . EUS-RFA was repeated at five more sites in the remaining viable tissue (▶ Fig. 3 b) . Follow-up CT at 1 week showed the adrenal mass almost completely replaced with necrotic tissue, without complications (▶ Fig. 1 b) . Serum and urine cortisol levels returned to normal the following day and remained normal for the next 2 months, with no adverse events related to RFA. However after the third month, the cortisol levels were re-elevated and this time the patient agreed to surgery. Until recently, there were only a few case reports of RFA for the treatment of Cushing's syndrome; all of them were treated via the CT-guided percutaneous method [1, 2] . The present case is the first in which EUS-RFA was used to manage Cushing's syndrome caused by adrenal adenoma. This case report supports EUS-RFA as a safe and feasible alternative method that should be considered in patients who refuse surgical treatment. Further evidence and experiences are required.
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